TFA Therapeutics (RAJAF) Other Accumulated Expenses (2022 - 2025)

TFA Therapeutics has reported Other Accumulated Expenses for 4 years, with the latest figure at $7892.0 in Q4 2025.

• On a quarterly basis, Other Accumulated Expenses rose 51.01% year-over-year to $7892.0 in Q4 2025; TTM through Dec 2025 was $7892.0, a 51.01% increase from a year earlier, with the FY2025 full-year figure at $7892.0, up 51.01% from the prior year.
• Other Accumulated Expenses was $7892.0 for Q4 2025 at TFA Therapeutics, up from $5226.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $2.6 million in Q4 2023, with the low at $5226.0 in Q4 2024.
• Average Other Accumulated Expenses over 4 years is $999246.8, with a median of $693084.5 recorded in 2022.
• The sharpest annual moves came in 2023 and 2024: Other Accumulated Expenses jumped 89.05% in 2023, then tumbled 99.8% in 2024.
• Over 4 years, Other Accumulated Expenses stood at $1.4 million in 2022, then surged by 89.05% to $2.6 million in 2023, then plunged by 99.8% to $5226.0 in 2024, then jumped by 51.01% to $7892.0 in 2025.
• The last three Other Accumulated Expenses figures came in at $7892.0 (Q4 2025), $5226.0 (Q4 2024), and $2.6 million (Q4 2023), per Business Quant data.